Literature DB >> 21199139

Histoplasmosis and paracoccidioidomycosis in a non-endemic area: a review of cases and diagnosis.

Maria J Buitrago1, Leticia Bernal-Martínez, Maria V Castelli, Juan L Rodríguez-Tudela, Manuel Cuenca-Estrella.   

Abstract

BACKGROUND: Histoplasmosis and paracoccidioidomycosis (PCM) have increased in Spain in recent years, due firstly to the migration from endemic regions and secondly to travelers returning from these regions. In non-endemic areas, diagnosis of both diseases is hampered by the lack of experience, long silent periods, and the resemblance to other diseases such as tuberculosis and sarcoidosis.
METHODS: A total of 39 cases of imported histoplasmosis and 6 cases of PCM diagnosed in the Spanish Mycology Reference Laboratory since 2006 were analyzed. Microbiological diagnosis was performed using classical methods and also a specific real-time polymerase chain reaction (RT-PCR) assay for each microorganism.
RESULTS: We had 9 cases of probable histoplasmosis in travelers and 30 cases in immigrants, 29 of whom were defined as proven. Paracoccidioidomycosis (PCM) cases were either immigrants or people who had lived for a long period of time in endemic regions, all of whom were classified as proven cases. Cultures showed a good sensitivity in detecting Histoplasma capsulatum in immigrants with proven histoplasmosis (73%); however, growth was very slow. The fungus was never recovered in traveler patients. Paracoccidioides brasiliensis was isolated in a culture only in one case of the proven PCM. Serological methods were not very reliable in immunocompromised patients with histoplasmosis (40%). A PCR-based technique for histoplasmosis detected 55.5% of the cases in travelers (probable cases) and 89% of the cases in immigrants (proven). The PCR method for PCM detected 100% of the cases.
CONCLUSIONS: These kinds of mycoses are increasingly frequent in non-endemic areas, and newer and faster techniques should be used to reach an early diagnosis. The RT-PCR techniques developed appear to be sensitive, specific, and fast and could be helpful to detect those mycoses. However, it is also essential that physicians perform differential diagnosis in individuals coming from endemic areas.
© 2010 International Society of Travel Medicine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21199139     DOI: 10.1111/j.1708-8305.2010.00477.x

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  17 in total

1.  Histoplasmosis infections worldwide: thinking outside of the Ohio River valley.

Authors:  Nathan C Bahr; Spinello Antinori; L Joseph Wheat; George A Sarosi
Journal:  Curr Trop Med Rep       Date:  2015-06-01

Review 2.  Diagnosis of histoplasmosis: current status and perspectives.

Authors:  María Agustina Toscanini; Alejandro David Nusblat; María Luján Cuestas
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-15       Impact factor: 4.813

Review 3.  Progressive disseminated histoplasmosis in the HIV population in Europe in the HAART era. Case report and literature review.

Authors:  R Martin-Iguacel; J Kurtzhals; G Jouvion; S D Nielsen; J M Llibre
Journal:  Infection       Date:  2014-03-14       Impact factor: 3.553

4.  Serum Aspergillus galactomannan for the management of disseminated histoplasmosis in AIDS.

Authors:  Sébastien Rivière; Blandine Denis; Marie-Elisabeth Bougnoux; Fanny Lanternier; Marc Lecuit; Olivier Lortholary
Journal:  Am J Trop Med Hyg       Date:  2012-08       Impact factor: 2.345

5.  Differential Diagnosis of Fungal Pneumonias vs. Tuberculosis in AIDS Patients by Using Two New Molecular Methods.

Authors:  Leticia Bernal-Martínez; Laura Herrera; Clara Valero; Paula de la Cruz; Larisa Ghimpu; Ana C Mesa-Arango; Gabriela Santoni; Lidia Goterris; Rosario Millán; María José Buitrago
Journal:  J Fungi (Basel)       Date:  2021-04-27

6.  Antifungal Activity of Decyl Gallate against Several Species of Pathogenic Fungi.

Authors:  Ana Carolina Alves de Paula E Silva; Caroline Barcelos Costa-Orlandi; Fernanda Patrícia Gullo; Fernanda Sangalli-Leite; Haroldo Cesar de Oliveira; Julhiany de Fátima da Silva; Liliana Scorzoni; Nayla de Souza Pitangui; Suélen Andrea Rossi; Tatiane Benaducci; Vanessa Gonçalves Wolf; Luis Octávio Regasini; Maicon Segalla Petrônio; Dulce Helena Siqueira Silva; Vanderlan S Bolzani; Ana Marisa Fusco-Almeida; Maria José Soares Mendes-Giannini
Journal:  Evid Based Complement Alternat Med       Date:  2014-11-20       Impact factor: 2.629

7.  Severe Changes in Thymic Microenvironment in a Chronic Experimental Model of Paracoccidioidomycosis.

Authors:  Thiago Alves da Costa; Rosária Di Gangi; Rodolfo Thomé; Marina Barreto Felisbino; Amanda Pires Bonfanti; Larissa Lumi Watanabe Ishikawa; Alexandrina Sartori; Eva Burger; Liana Verinaud
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

8.  Chronic Paracoccidioidomycosis with adrenal involvement mimicking tuberculosis - A case report from Austria.

Authors:  Gernot Wagner; Deddo Moertl; Axel Eckhardt; Ulrich Sagel; Friedrich Wrba; Karl Dam; Birgit Willinger
Journal:  Med Mycol Case Rep       Date:  2016-12-02

9.  Retinal involvement of Paracoccioidomycosis: A Case Report.

Authors:  Thais Z Igami; Francisco Solano; Rony C Preti; Carla Pagliari; Walter Y Takahashi; Richard Y Hida
Journal:  Trop Med Health       Date:  2013-01-19

10.  Whole-body magnetic resonance imaging for the evaluation of thoracic involvement in disseminated paracoccidioidomycosis.

Authors:  Edson Marchiori; Elisa Carvalho Ferreira; Gláucia Zanetti; Bruno Hochhegger
Journal:  J Bras Pneumol       Date:  2013 Mar-Apr       Impact factor: 2.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.